Patents by Inventor Hiroatsu Sugimoto

Hiroatsu Sugimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240023948
    Abstract: The present disclosure relates to a method and a device for treating heart failure by normalizing elevated blood pressure in the left and right atria of a heart of a mammal. The present disclosure includes methods for creating and maintaining an opening in the atrial septum. Tools for making an opening and enlarging the opening are also disclosed. Use of the techniques and tools described herein prolongs the patency of an intra-atrial pressure relief opening.
    Type: Application
    Filed: February 24, 2023
    Publication date: January 25, 2024
    Inventors: David S. CELERMAJER, Edward I. MCNAMARA, Michael W. SUTHERLAND, Hiroatsu SUGIMOTO
  • Patent number: 11660190
    Abstract: Systems, devices and methods for securing tissue including the annulus of a mitral valve. The systems, devices and methods may employ catheter based techniques and devices to plicate tissue and perform an annuloplasty.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: May 30, 2023
    Assignee: EDWARDS LIFESCIENCES CORPORATION
    Inventors: Paul A. Spence, Donald S. Baim, Edward I. McNamara, Hiroatsu Sugimoto, Joseph P. Lane, Jason H. Robinson, Aaron M. Call, Steven D. Cahalane, Mark Maguire, Kate E. Cutuli
  • Patent number: 11589854
    Abstract: The present disclosure relates to a method and a device for treating heart failure by normalizing elevated blood pressure in the left and right atria of a heart of a mammal. The present disclosure includes methods for creating and maintaining an opening in the atrial septum. Tools for making an opening and enlarging the opening are also disclosed. Use of the techniques and tools described herein prolongs the patency of an intra-atrial pressure relief opening.
    Type: Grant
    Filed: May 20, 2019
    Date of Patent: February 28, 2023
    Assignee: Corvia Medical, Inc.
    Inventors: David S. Celermajer, Edward I. McNamara, Michael W. Sutherland, Hiroatsu Sugimoto
  • Publication number: 20220313234
    Abstract: Several unique intra-cardiac pressure devices, placement catheters, methods of placement and methods of treating heart failure are presented. The intra-cardiac pressure devices presented allow sufficient flow from the left atrium to the right atrium to enable the relief of elevated left atrial pressure and resulting patient symptoms. The intra-cardiac pressure devices are made of a non-braided material.
    Type: Application
    Filed: November 8, 2021
    Publication date: October 6, 2022
    Inventors: Edward MCNAMARA, David S. CELERMAJER, Stephen J. FORCUCCI, Hiroatsu SUGIMOTO
  • Patent number: 11166705
    Abstract: Several unique intra-cardiac pressure devices, placement catheters, methods of placement and methods of treating heart failure are presented. The intra-cardiac pressure devices presented allow sufficient flow from the left atrium to the right atrium to enable the relief of elevated left atrial pressure and resulting patient symptoms. The intra-cardiac pressure devices are made of a non-braided material.
    Type: Grant
    Filed: May 14, 2012
    Date of Patent: November 9, 2021
    Assignee: Corvia Medical, Inc.
    Inventors: Edward McNamara, David Celermajer, Stephen Forcucci, Hiroatsu Sugimoto
  • Publication number: 20210177390
    Abstract: Several unique intra-cardiac pressure devices, placement catheters, methods of placement and methods of treating heart failure are presented. The intra-cardiac pressure devices presented allow sufficient flow from the left atrium to the right atrium to enable the relief of elevated left atrial pressure and resulting patient symptoms. The intra-cardiac pressure devices are made of a non-braided material.
    Type: Application
    Filed: May 14, 2012
    Publication date: June 17, 2021
    Inventors: Edward McNamara, David Celermajer, Stephen Forcucci, Hiroatsu Sugimoto
  • Publication number: 20200330088
    Abstract: An annuloplasty implant comprising an elongate member configured to be anchored to tissue of a heart, and to move between an elongate configuration and a shortened configuration and a tensioning member. The tensioning member can define a first segment and a second segment such that the first segment extends between a first tensioning-member end and a turn of the tensioning member, and the second segment extends between the turn and the second tensioning-member end. The tensioning member extends along the elongate member such that the elongate member can slide relative to the tensioning member and such that applying tension to the tensioning member causes the elongate member to move from the elongate configuration to the shortened configuration, which can cause the implant to reshape an annulus of a heart valve.
    Type: Application
    Filed: June 29, 2020
    Publication date: October 22, 2020
    Inventors: Hiroatsu Sugimoto, Aaron M. Call, Karl R. Leinsing
  • Patent number: 10695046
    Abstract: A tissue anchor includes an anchor member formed from a generally flexible material. An activation member, which may be a tensioning member, causes proximal and distal end portions of the anchor member to move toward each other into a shortened configuration suitable for anchoring against the tissue. The tissue anchor can optionally be deployed and activated using a catheter device.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: June 30, 2020
    Assignee: Edwards Lifesciences Corporation
    Inventors: Hiroatsu Sugimoto, Aaron M. Call, Karl R. Leinsing
  • Patent number: 10588611
    Abstract: The present teachings generally relate a delivery system having an implant retention mechanism. Specifically, the delivery system includes a delivery sheath, a delivery catheter, and a flexible or a rigid implant retention mechanism. The flexible implant retention mechanism includes an implant retention string having a fixed end and a free end where the free end extends from the fixed end, crosses a retention outlet of an implant, and extends proximally through a lumen of the delivery sheath. The rigid implant retention mechanism includes an implant retention wire having a fixed end and a free end where the free end extends from the fixed end, crosses a retention outlet of an implant, and extends proximally through a lumen of the delivery sheath.
    Type: Grant
    Filed: April 19, 2013
    Date of Patent: March 17, 2020
    Assignee: Corvia Medical Inc.
    Inventors: Christopher J. Magnin, Matthew J. Finch, Hiroatsu Sugimoto, Stephen J. Forcucci
  • Patent number: 10413286
    Abstract: The invention is a septal implant that can accommodate variable thicknesses of the patient's atrial septum as well the variable thicknesses of septums across a population. The invention is able to accomplish this result by having flexible annular flanges that define a gap into which the septum fits. Due to the flexible nature of the annular flanges, the gap is adjustable.
    Type: Grant
    Filed: May 14, 2012
    Date of Patent: September 17, 2019
    Assignee: CORVIA MEDICAL, INC.
    Inventors: Edward McNamara, David Celermajer, Stephen J. Forcucci, Hiroatsu Sugimoto
  • Patent number: 10413284
    Abstract: The present disclosure relates to improved capabilities for stabilizing and regulating atrial pressure with a shunt in the atrial septum or a stent in the coronary sinus. The disclosure also includes sensing, monitoring, drug therapy and control capabilities to provide improved treatment of patients with heart disease and other cardiac related conditions.
    Type: Grant
    Filed: April 18, 2012
    Date of Patent: September 17, 2019
    Assignee: Corvia Medical, Inc.
    Inventors: Edward McNamara, Matthew J. Finch, Hiroatsu Sugimoto, Stephen Forcucci, Harith Rajagopalan
  • Publication number: 20190269392
    Abstract: The present disclosure relates to a method and a device for treating heart failure by normalizing elevated blood pressure in the left and right atria of a heart of a mammal. The present disclosure includes methods for creating and maintaining an opening in the atrial septum. Tools for making an opening and enlarging the opening are also disclosed. Use of the techniques and tools described herein prolongs the patency of an intra-atrial pressure relief opening.
    Type: Application
    Filed: May 20, 2019
    Publication date: September 5, 2019
    Inventors: David S. CELERMAJER, Edward I. MCNAMARA, Michael W. SUTHERLAND, Hiroatsu SUGIMOTO
  • Publication number: 20190240023
    Abstract: Systems, devices and methods for securing tissue including the annulus of a mitral valve. The systems, devices and methods may employ catheter based techniques and devices to plicate tissue and perform an annuloplasty.
    Type: Application
    Filed: February 6, 2019
    Publication date: August 8, 2019
    Applicant: Edwards Lifesciences Corporation
    Inventors: Paul A. Spence, Donald S. Baim, Edward I. McNamara, Hiroatsu Sugimoto, Joseph P. Lane, Jason H. Robinson, Aaron M. Call, Steven D. Cahalane, Mark Maguire, Kate E. Cutuli
  • Patent number: 10292690
    Abstract: The present disclosure relates to a method and a device for treating heart failure by normalizing elevated blood pressure in the left and right atria of a heart of a mammal. The present disclosure includes methods for creating and maintaining an opening in the atrial septum. Tools for making an opening and enlarging the opening are also disclosed. Use of the techniques and tools described herein prolongs the patency of an intra-atrial pressure relief opening.
    Type: Grant
    Filed: May 30, 2013
    Date of Patent: May 21, 2019
    Assignee: Corvia Medical, Inc.
    Inventors: David Celermajer, Edward McNamara, Michael W. Sutherland, Hiroatsu Sugimoto
  • Patent number: 10188375
    Abstract: Several unique intra-cardiac pressure vents, placement catheters, methods of placement and methods of treating heart failure are presented. The intra-cardiac pressure vents presented remain partially open under normal intra-cardiac pressures to allow sufficient flow from the left atrium to the right atrium to enable the relief of elevated left atrial pressure and resulting patient symptoms, and also limit the amount of flow from the right atrium to the left atrium by closing when the pressure in the right atrium exceeds the pressure in the left atrium by a predetermined amount.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: January 29, 2019
    Assignee: Corvia Medical, Inc.
    Inventors: Edward McNamara, David Celermajer, Stephen J. Forcucci, Hiroatsu Sugimoto, Matthew J. Finch
  • Patent number: 10045766
    Abstract: Several unique intracardiac pressure vents, placement catheters, methods of placement and methods of treating heart failure are presented. The intracardiac pressure vents presented allow sufficient flow from the left atrium to the right atrium to relieve elevated left atrial pressure and resulting patient symptoms but also limit the amount of flow from the right atrium to the left atrium to minimize the potential for thrombus or other embolic material from entering the arterial circulation.
    Type: Grant
    Filed: November 17, 2011
    Date of Patent: August 14, 2018
    Assignee: Corvia Medical, Inc.
    Inventors: Edward McNamara, David Celermajer, Stephen J. Forcucci, Hiroatsu Sugimoto, Matthew J. Finch
  • Publication number: 20180099128
    Abstract: The invention is a septal implant that can accommodate variable thicknesses of the patient's atrial septum as well the variable thicknesses of septums across a population. The invention is able to accomplish this result by having flexible annular flanges that define a gap into which the septum fits. Due to the flexible nature of the annular flanges, the gap is adjustable.
    Type: Application
    Filed: May 14, 2012
    Publication date: April 12, 2018
    Inventors: Edward McNamara, David Celermajer, Stephen J. Forcucci, Hiroatsu Sugimoto
  • Patent number: 9937036
    Abstract: Devices and methods to enhance the implantation, retrievability, or repositionability are provided. Embodiments of devices include pivotable sections providing the ability to maintain the device's engagement with a delivery system during implantation where the deliver system approaches an opening of the septum at an angle. Embodiments of devices also include configurations that allow for improved retrieval into a delivery system in the event that a malfunction or a problem with the patients physiology is detected.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: April 10, 2018
    Assignee: Corvia Medical, Inc.
    Inventors: Hiroatsu Sugimoto, Stephen J. Forcucci, Edward I. McNamara, Matthew J. Finch, Christopher J. Magnin
  • Publication number: 20180028171
    Abstract: A tissue anchor includes an anchor member formed from a generally flexible material. An activation member, which may be a tensioning member, causes proximal and distal end portions of the anchor member to move toward each other into a shortened configuration suitable for anchoring against the tissue. The tissue anchor can optionally be deployed and activated using a catheter device.
    Type: Application
    Filed: August 18, 2017
    Publication date: February 1, 2018
    Inventors: Hiroatsu Sugimoto, Aaron M. Call, Karl R. Leinsing
  • Patent number: 9814454
    Abstract: A tissue anchor includes an anchor member formed from a generally flexible material. An activation member, which may be a tensioning member, causes proximal and distal end portions of the anchor member to move toward each other into a shortened configuration suitable for anchoring against the tissue. The tissue anchor can optionally be deployed and activated using a catheter device.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: November 14, 2017
    Assignee: MITRALIGN, INC.
    Inventors: Hiroatsu Sugimoto, Aaron M. Call, Karl R. Leinsing